InvestorsHub Logo
Followers 8
Posts 357
Boards Moderated 0
Alias Born 07/30/2015

Re: Mandofellow post# 2925

Wednesday, 06/07/2017 4:50:19 PM

Wednesday, June 07, 2017 4:50:19 PM

Post# of 9941
They won't be ready to start trials on their EB drug for at least a year and more likely 18 months. Glaucoma is out further than that. Any news would come from Bioinformatics or Biosynthesis if they have value.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News